Cargando…
Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker
Metformin is widely used in the treatment of type 2 diabetes (T2D) and plays a role in antitumor and antiobesity processes. A recent study identified its direct molecular target, PEN2 (PSENEN). PSENEN is the minimal subunit of the multiprotein complex γ-secretase, which promotes the differentiation...
Autores principales: | Chen, Kaijie, Liang, Beibei, Ma, Wenhao, Wan, Guoqing, Chen, Bing, Lu, Changlian, Luo, Yuzhou, Gu, Xuefeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366120/ https://www.ncbi.nlm.nih.gov/pubmed/35966015 http://dx.doi.org/10.3389/fnmol.2022.933855 |
Ejemplares similares
-
A prognostic and therapeutic hallmark developed by the integrated profile of basement membrane and immune infiltrative landscape in lung adenocarcinoma
por: Chen, Kaijie, et al.
Publicado: (2022) -
PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma
por: Li, Peng, et al.
Publicado: (2022) -
Protective Prognostic Biomarkers Negatively Correlated with Macrophage M2 Infiltration in Low-Grade Glioma
por: Zhu, Yunyang, et al.
Publicado: (2022) -
New prognostic biomarker CMTM3 in low grade glioma and its immune infiltration
por: Li, Shoubin, et al.
Publicado: (2022) -
Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration
por: Ren, Xiaoyue, et al.
Publicado: (2023)